Source: International Congress 2019 – Mechanisms underlying respiratory infection
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
F. Sanz Herrero (Valencia, Spain), S. Vicente Ferrer (Valencia, Spain), M. Briones (Valencia, Spain), M. Martínez (Valencia, Spain), J. Lozada (Valencia, Spain), E. Fernández Fabellas (Valencia, Spain), A. Aibar (Valencia, Spain), S. Ferrer (Valencia, Spain), F. Dasí Fernández (Valencia, Spain). Circulating microRNAs can identify endotypes of community-acquired pneumonia. 5449

Member's Comments

No comment yet.

Related content which might interest you: Biomarkers in community-acquired pneumonia: still searching for the one Source: Eur Respir J, 53 (2) 1802469; 10.1183/13993003.02469-2018 Year: 2019 Biomarkers and clinical stability in community-acquired pneumonia Source: Annual Congress 2009 - Assessment of severity in respiratory infections: severity scales and biomarkers Year: 2009 Biomarkers in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Respiratory infections: a clinical point of view Year: 2012 Etiology pathogens structure in community-acquired pneumonias and COPD exacerbations Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Inflammatory pattern in bacteriemic community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Comparison of inflammatory response biomarkers to predict complications in hospitalized patients with community-acquired pneumonia Source: Annual Congress 2011 - Biomarkers and outcomes of community-acquired pneumonia Year: 2011 Pathogen- and antibiotic-specific effects of prednisone in community-acquired pneumonia Source: Eur Respir J 2016; 48: 1150-1159 Year: 2016 Community-acquired pneumonia Source: Respipedia Article Year: 2017 Biomarkers and cardiovascular events in community-acquired pneumonia Source: International Congress 2016 – Community-acquired pneumonia: update on prognostic factors and therapeutic strategies Year: 2016 Serum procalcitonin and community-acquired pneumonia in childhood Source: Eur Respir J 2005; 26: Suppl. 49, 167s Year: 2005 Risk factors for pulmonary tuberculosis in community-acquired pneumonia Source: Eur Respir J 2014; 43: 1214 Year: 2014 Risk factors for pulmonary tuberculosis in community-acquired pneumonia Source: Eur Respir J 2014; 43: 1213 Year: 2014 Biomarkers and severity in community-acquired pneumonia (CAP) Source: Annual Congress 2012 - Prognostic indices in respiratory infections Year: 2012 Cytokine responses, microbial etiology and short-term outcome in community-acquired pneumonia Source: International Congress 2017 – CAP: severity scores, risk groups and biomarkers Year: 2017 Corticosteroids and community-acquired pneumonia Source: Annual Congress 2007 - Corticosteroids and respiratory failure Year: 2007 Relationship between etiologic diagnosis and prognosis in community-acquired pneumonia Source: International Congress 2015 – Clinical issues in CAP: microbiological and radiological determinants Year: 2015 Validation of pneumonia severity models for healthcare-associated pneumonia (HCAP) Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Metabolomic analysis of infectious parapneumonic effusions reveals biomarkers for management of children with streptococcus pneumoniae pneumonia Source: International Congress 2016 – Paediatric respiratory infection and immunology Year: 2016 Predisposing factors for bacteremia in patients with community-acquired pneumonia and positive pneumococcal urinary antigen Source: International Congress 2016 – Community-acquired pneumonia: from prevention to treatment Year: 2016 Features of systemic inflammation in patients with severe community-acquired (CAP) pneumonia of different etiology in HIV-infected patients Source: International Congress 2015 – Immunodepression and severe pneumonia Year: 2015